Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 8/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.82 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.82 |
| ▸ | MAPT | P10636 | 5/20 | 0.75 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | APP | P05067 | 1/20 | 0.67 |
| ▸ | GSK3B | P49841 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979408 | 0.90 | CYP1B1 (1.00) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL9503680 | 0.90 | CYP1B1 (1.00) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL31436361 | 0.87 | CYP1A1 (0.77) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL1322027 | 0.87 | CYP1A1 (0.82) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL1322029 | 0.87 | CYP1A1 (0.82) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL1604142 | 0.87 | CYP1A1 (0.77) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL31436369 | 0.87 | CYP1A1 (0.77) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL2705060 | 0.86 | MAPT (1.00) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL9804079 | 0.86 | MAPT (1.00) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 | |
| SCHEMBL3024151 | 0.86 | CYP1B1 (0.75) | CYP1A1CYP1A2CYP1B1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304597-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-10-02 | — | — | US | disclosed |
| US-20240043440-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-02-08 | — | — | US | disclosed |
| US-20210317132-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-10-14 | — | — | US | disclosed |
| US-20210317132-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-10-14 | — | — | US | disclosed |
| CN-111132982-A | Compositions and methods for modulating short-chain dehydrogenase activity | 卡斯西部储备大学 | 2020-05-08 | — | — | CN | disclosed |
| EP-3630773-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | Case Western Reserve University (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018218251-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | CASE WESTERN RESERVE UNIVERSITY (US) | 2018-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304597-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | CYP1A1 816/4885CYP1A2 463/4885CYP1B1 830/4885 |
| US-20210317132-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | CYP1A1 816/4885CYP1A2 463/4885CYP1B1 830/4885 |
| US-20240043440-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | CYP1A1 816/4885CYP1A2 463/4885CYP1B1 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.